DRIEHAUS CAPITAL MANAGEMENT LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 61 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
DRIEHAUS CAPITAL MANAGEMENT LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q4 2014$3,034,000
+10.1%
81,047
+2.8%
0.12%
+16.2%
Q3 2014$2,755,000
-23.0%
78,851
+2.6%
0.10%
-9.5%
Q2 2014$3,576,000
+69.2%
76,820
+12.3%
0.12%
+73.1%
Q1 2014$2,114,000
+2.2%
68,427
-24.1%
0.07%
-10.7%
Q4 2013$2,068,00090,2070.08%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders